Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Sector Analysis

UpdatedAug 10, 2025
DataAggregated Company Financials
Companies1387
  • 7D-0.9%
  • 3M-3.1%
  • 1Y-13.3%
  • YTD-6.8%

The Healthcare is pretty flat in the last 7 days, but Johnson & Johnson has stood out, gaining 3.6%. Unfortunately though, the industry is down 13% over the past 12 months. Earnings are forecast to grow by 15% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 10 Aug 2025US$5.4tUS$3.1tUS$139.6b23.3x38.5x1.7x
Tue, 08 Jul 2025US$5.6tUS$3.0tUS$127.9b24x43.4x1.8x
Thu, 05 Jun 2025US$5.4tUS$3.0tUS$127.3b23.5x42.6x1.8x
Sat, 03 May 2025US$5.5tUS$2.7tUS$124.5b25x44.1x2x
Mon, 31 Mar 2025US$5.6tUS$2.6tUS$81.7b26.4x69.1x2.1x
Wed, 26 Feb 2025US$5.8tUS$2.6tUS$80.9b26.2x72.2x2.2x
Fri, 24 Jan 2025US$6.0tUS$2.9tUS$85.4b27.1x69.9x2x
Sun, 22 Dec 2024US$5.8tUS$2.9tUS$78.2b27.7x73.5x2x
Tue, 19 Nov 2024US$5.9tUS$2.9tUS$76.6b27.5x77.4x2x
Thu, 17 Oct 2024US$6.2tUS$2.8tUS$58.6b30.3x106.3x2.2x
Sat, 14 Sep 2024US$6.3tUS$2.8tUS$60.3b30.6x104.4x2.2x
Mon, 12 Aug 2024US$6.0tUS$2.8tUS$55.3b30.3x108.9x2.1x
Wed, 10 Jul 2024US$6.1tUS$2.8tUS$62.2b29.5x98.5x2.2x
Fri, 07 Jun 2024US$6.2tUS$2.8tUS$63.7b30.4x97.2x2.2x
Sun, 05 May 2024US$6.0tUS$2.8tUS$65.2b31.1x92.6x2.1x
Tue, 02 Apr 2024US$6.4tUS$2.8tUS$83.9b32.8x75.7x2.3x
Thu, 29 Feb 2024US$6.3tUS$2.8tUS$85.7b30.5x73.9x2.3x
Sat, 27 Jan 2024US$6.3tUS$2.8tUS$90.7b32x69.4x2.2x
Mon, 25 Dec 2023US$6.2tUS$2.8tUS$91.6b33.1x67.4x2.2x
Wed, 22 Nov 2023US$5.8tUS$2.8tUS$90.7b27.8x63.6x2x
Fri, 20 Oct 2023US$5.8tUS$2.8tUS$99.5b25.7x58x2.1x
Sun, 17 Sep 2023US$6.0tUS$2.8tUS$98.6b29.3x61x2.2x
Tue, 15 Aug 2023US$6.2tUS$2.8tUS$98.9b28.4x62.9x2.2x
Thu, 13 Jul 2023US$5.9tUS$2.7tUS$110.3b26.3x53.5x2.2x
Sat, 10 Jun 2023US$6.0tUS$2.7tUS$110.4b25.2x53.9x2.2x
Mon, 08 May 2023US$6.0tUS$2.7tUS$114.0b25x53x2.2x
Wed, 05 Apr 2023US$5.8tUS$2.5tUS$121.8b24.3x47.8x2.3x
Fri, 03 Mar 2023US$5.7tUS$2.5tUS$122.9b25.1x46.5x2.3x
Sun, 29 Jan 2023US$6.0tUS$2.5tUS$133.9b23.8x44.6x2.4x
Tue, 27 Dec 2022US$6.0tUS$2.5tUS$135.7b23x44.3x2.5x
Thu, 24 Nov 2022US$6.0tUS$2.4tUS$133.7b24x44.9x2.5x
Sat, 22 Oct 2022US$5.7tUS$2.4tUS$156.8b21.6x36x2.3x
Mon, 19 Sep 2022US$5.8tUS$2.4tUS$156.2b21.7x36.9x2.4x
Wed, 17 Aug 2022US$6.1tUS$2.4tUS$156.9b23.8x39x2.5x
Price to Earnings Ratio

39x


Total Market Cap: US$6.1tTotal Earnings: US$156.9bTotal Revenue: US$2.4tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 64.5x202320242025
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 38.5x which is lower than its 3-year average PE of 64.5x.
  • The 3-year average PS ratio of 2.2x is higher than the industry's current PS ratio of 1.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 3.8% per year over the last three years.
  • Meanwhile revenues for these companies have grown 8.9% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market2.39%
Healthcare-0.91%
Healthcare Services4.08%
Medical Equipment2.12%
Healthtech1.97%
Life Sciences-0.34%
Biotech-1.46%
Pharma-5.30%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 57.4x.
    • Analysts are expecting annual earnings growth of 12.4%, which is lower than the prior year's growth of 16.0% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 24% over the next 5 years.
  • However this is lower than its past earnings growth rate of 65% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
JNJ Johnson & JohnsonUS$173.333.6%
+US$14.5b		7.9%PE18.4x
ABT Abbott LaboratoriesUS$134.285.5%
+US$12.2b		23.5%PE16.8x
UNH UnitedHealth GroupUS$250.895.5%
+US$11.9b		-55.1%PE10.7x
IDXX IDEXX LaboratoriesUS$658.0622.9%
+US$9.6b		36.3%PE53.4x
GILD Gilead SciencesUS$119.415.5%
+US$7.4b		62.1%PE23.5x

Latest News

HIMS
US$51.94
Hims & Hers Health
7D
-17.0%
1Y
225.4%
BDX
US$193.50
Becton Dickinson
7D
9.7%
1Y
-18.0%
LLY
US$625.65
Eli Lilly
7D
-17.9%
1Y
-29.8%
GILD
US$119.41
Gilead Sciences
7D
5.5%
1Y
62.1%
ABBV
US$198.05
AbbVie
7D
1.4%
1Y
4.3%
VRTX
US$366.54
Vertex Pharmaceuticals
7D
-20.7%
1Y
-21.8%
MCK
US$668.58
McKesson
7D
-4.3%
1Y
23.5%
IDXX
US$658.06
IDEXX Laboratories
7D
22.9%
1Y
36.3%
AMGN
US$288.23
Amgen
7D
-2.9%
1Y
-10.6%
ONC
US$288.18
BeOne Medicines
7D
-3.6%
1Y
57.7%
PFE
US$24.58
Pfizer
7D
4.6%
1Y
-13.9%
UNH
US$250.89
UnitedHealth Group
7D
5.5%
1Y
-55.1%
BSX
US$103.14
Boston Scientific
7D
-2.2%
1Y
35.4%
JNJ
US$173.33
Johnson & Johnson
7D
3.6%
1Y
7.9%
ISRG
US$470.08
Intuitive Surgical
7D
-2.7%
1Y
1.4%
ABT
US$134.28
Abbott Laboratories
7D
5.5%
1Y
23.5%